Inmed Pharmaceuticals Inc. · NASDAQ:INM
Inmed Pharmaceuticals Inc. shareholders
As of Jun 30, 2026, 19 institutions reported holding Inmed Pharmaceuticals Inc., 49.1% of its shares. Largest: ADAR1 Capital Management, LLC, Vivo Capital, LLC and Squadron Capital Management LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Inmed Pharmaceuticals Inc. | Change | Filed |
|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 800K | 14.6% | new | Aug 14, 2026 |
| Vivo Capital, LLC | 798K | 14.5% | new | Aug 14, 2026 |
| Squadron Capital Management LLC | 325K | 5.9% | new | Aug 14, 2026 |
| Ikarian Capital, LLC | 245K | 4.5% | new | Aug 14, 2026 |
| Ursa Fund Management, LLC | 126K | 2.3% | new | Aug 14, 2026 |
| Montanova Capital, LLC | 100K | 1.8% | new | Aug 14, 2026 |
| Boothbay Fund Management, LLC | 74,244 | 1.4% | new | Aug 14, 2026 |
| Sabby Management, LLC | 44,970 | 0.82% | −175K | Aug 14, 2026 |
| Jane Street | 43,078 | 0.78% | new | Aug 14, 2026 |
| Venrock Adviser, LLC | 32,685 | 0.59% | new | Aug 14, 2026 |